Login / Signup

Letter: Comparing first-line infliximab and vedolizumab for ulcerative colitis-It depends on how you use the drug. Authors' reply.

Bernd BokemeyerSandra Plachta-Danielzik
Published in: Alimentary pharmacology & therapeutics (2023)
Keyphrases
  • ulcerative colitis
  • adverse drug
  • drug induced
  • patients with inflammatory bowel disease